INT IMMUNOPHARMACOL 润色咨询

INTERNATIONAL IMMUNOPHARMACOLOGY

出版年份：2001 年文章数：5633 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：4.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学;生信<br>经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：12.25投稿<br>2.27大修<br>3.17修回<br>4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199829, encodeId=394f2199829ce, content=大家一般with editor后多久转状态呀，好慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=ms9000001723608318, createdTime=Mon Apr 22 19:35:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198038, encodeId=5e352198038f0, content=偏重的研究方向：免疫药理<br>经验分享：这个期刊重复率有要求不能超过多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6655154625, createdName=木之禾66, createdTime=Thu Apr 11 22:00:34 CST 2024, time=2024-04-11, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2184149, encodeId=f961218414981, content=慢的死，这个杂志好慢，with editor半个月了，有人有经验么，想换个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Fri Jan 26 17:51:42 CST 2024, time=2024-01-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197730, encodeId=b939219e7305c, content=Mar 09, 2024投稿，现在还是在审稿中，无奈焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 10 13:16:34 CST 2024, time=2024-04-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿；1215送审；1月9号收到大修；2月2日返稿，2月14日接收，2月19日proof。大修要了所以WB原图，至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省)]
    2024-04-04 WWW9450 来自山东省

    现在稿号到多少了

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学;生信<br>经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：12.25投稿<br>2.27大修<br>3.17修回<br>4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199829, encodeId=394f2199829ce, content=大家一般with editor后多久转状态呀，好慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=ms9000001723608318, createdTime=Mon Apr 22 19:35:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198038, encodeId=5e352198038f0, content=偏重的研究方向：免疫药理<br>经验分享：这个期刊重复率有要求不能超过多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6655154625, createdName=木之禾66, createdTime=Thu Apr 11 22:00:34 CST 2024, time=2024-04-11, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2184149, encodeId=f961218414981, content=慢的死，这个杂志好慢，with editor半个月了，有人有经验么，想换个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Fri Jan 26 17:51:42 CST 2024, time=2024-01-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197730, encodeId=b939219e7305c, content=Mar 09, 2024投稿，现在还是在审稿中，无奈焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 10 13:16:34 CST 2024, time=2024-04-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿；1215送审；1月9号收到大修；2月2日返稿，2月14日接收，2月19日proof。大修要了所以WB原图，至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省)]
    2024-01-09 洛洛仔111 来自北京

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向：免疫学;生信
    经验分享：投了五天了还是submit状态，后续更新进度

    34

    展开34条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学;生信<br>经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：12.25投稿<br>2.27大修<br>3.17修回<br>4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199829, encodeId=394f2199829ce, content=大家一般with editor后多久转状态呀，好慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=ms9000001723608318, createdTime=Mon Apr 22 19:35:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198038, encodeId=5e352198038f0, content=偏重的研究方向：免疫药理<br>经验分享：这个期刊重复率有要求不能超过多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6655154625, createdName=木之禾66, createdTime=Thu Apr 11 22:00:34 CST 2024, time=2024-04-11, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2184149, encodeId=f961218414981, content=慢的死，这个杂志好慢，with editor半个月了，有人有经验么，想换个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Fri Jan 26 17:51:42 CST 2024, time=2024-01-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197730, encodeId=b939219e7305c, content=Mar 09, 2024投稿，现在还是在审稿中，无奈焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 10 13:16:34 CST 2024, time=2024-04-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿；1215送审；1月9号收到大修；2月2日返稿，2月14日接收，2月19日proof。大修要了所以WB原图，至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省)]
    2024-04-24 ms2000002142798745 来自江苏省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：免疫;肿瘤
    经验分享：12.25投稿
    2.27大修
    3.17修回
    4.18RRC到现在，是不是希望不大了，能写信催一下吗？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学;生信<br>经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：12.25投稿<br>2.27大修<br>3.17修回<br>4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199829, encodeId=394f2199829ce, content=大家一般with editor后多久转状态呀，好慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=ms9000001723608318, createdTime=Mon Apr 22 19:35:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198038, encodeId=5e352198038f0, content=偏重的研究方向：免疫药理<br>经验分享：这个期刊重复率有要求不能超过多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6655154625, createdName=木之禾66, createdTime=Thu Apr 11 22:00:34 CST 2024, time=2024-04-11, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2184149, encodeId=f961218414981, content=慢的死，这个杂志好慢，with editor半个月了，有人有经验么，想换个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Fri Jan 26 17:51:42 CST 2024, time=2024-01-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197730, encodeId=b939219e7305c, content=Mar 09, 2024投稿，现在还是在审稿中，无奈焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 10 13:16:34 CST 2024, time=2024-04-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿；1215送审；1月9号收到大修；2月2日返稿，2月14日接收，2月19日proof。大修要了所以WB原图，至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省)]
    2024-04-12 ms5000001369677749 来自江苏省

    一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学;生信<br>经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：12.25投稿<br>2.27大修<br>3.17修回<br>4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199829, encodeId=394f2199829ce, content=大家一般with editor后多久转状态呀，好慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=ms9000001723608318, createdTime=Mon Apr 22 19:35:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198038, encodeId=5e352198038f0, content=偏重的研究方向：免疫药理<br>经验分享：这个期刊重复率有要求不能超过多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6655154625, createdName=木之禾66, createdTime=Thu Apr 11 22:00:34 CST 2024, time=2024-04-11, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2184149, encodeId=f961218414981, content=慢的死，这个杂志好慢，with editor半个月了，有人有经验么，想换个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Fri Jan 26 17:51:42 CST 2024, time=2024-01-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197730, encodeId=b939219e7305c, content=Mar 09, 2024投稿，现在还是在审稿中，无奈焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 10 13:16:34 CST 2024, time=2024-04-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿；1215送审；1月9号收到大修；2月2日返稿，2月14日接收，2月19日proof。大修要了所以WB原图，至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省)]
    2024-04-22 ms9000001723608318 来自广东省

    大家一般with editor后多久转状态呀，好慢呀

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学;生信<br>经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：12.25投稿<br>2.27大修<br>3.17修回<br>4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199829, encodeId=394f2199829ce, content=大家一般with editor后多久转状态呀，好慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=ms9000001723608318, createdTime=Mon Apr 22 19:35:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198038, encodeId=5e352198038f0, content=偏重的研究方向：免疫药理<br>经验分享：这个期刊重复率有要求不能超过多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6655154625, createdName=木之禾66, createdTime=Thu Apr 11 22:00:34 CST 2024, time=2024-04-11, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2184149, encodeId=f961218414981, content=慢的死，这个杂志好慢，with editor半个月了，有人有经验么，想换个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Fri Jan 26 17:51:42 CST 2024, time=2024-01-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197730, encodeId=b939219e7305c, content=Mar 09, 2024投稿，现在还是在审稿中，无奈焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 10 13:16:34 CST 2024, time=2024-04-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿；1215送审；1月9号收到大修；2月2日返稿，2月14日接收，2月19日proof。大修要了所以WB原图，至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省)]
    2024-03-28 ms1000001286002339 来自四川省

    偏重的研究方向：免疫;炎症
    经验分享：记录状态：
    2024.03.15提交手稿
    2024.03.18With Editor
    发过一封催稿邮件没有回复

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学;生信<br>经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：12.25投稿<br>2.27大修<br>3.17修回<br>4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199829, encodeId=394f2199829ce, content=大家一般with editor后多久转状态呀，好慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=ms9000001723608318, createdTime=Mon Apr 22 19:35:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198038, encodeId=5e352198038f0, content=偏重的研究方向：免疫药理<br>经验分享：这个期刊重复率有要求不能超过多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6655154625, createdName=木之禾66, createdTime=Thu Apr 11 22:00:34 CST 2024, time=2024-04-11, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2184149, encodeId=f961218414981, content=慢的死，这个杂志好慢，with editor半个月了，有人有经验么，想换个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Fri Jan 26 17:51:42 CST 2024, time=2024-01-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197730, encodeId=b939219e7305c, content=Mar 09, 2024投稿，现在还是在审稿中，无奈焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 10 13:16:34 CST 2024, time=2024-04-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿；1215送审；1月9号收到大修；2月2日返稿，2月14日接收，2月19日proof。大修要了所以WB原图，至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省)]
    2024-04-11 木之禾66 来自吉林

    偏重的研究方向：免疫药理
    经验分享：这个期刊重复率有要求不能超过多少吗？

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学;生信<br>经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：12.25投稿<br>2.27大修<br>3.17修回<br>4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199829, encodeId=394f2199829ce, content=大家一般with editor后多久转状态呀，好慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=ms9000001723608318, createdTime=Mon Apr 22 19:35:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198038, encodeId=5e352198038f0, content=偏重的研究方向：免疫药理<br>经验分享：这个期刊重复率有要求不能超过多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6655154625, createdName=木之禾66, createdTime=Thu Apr 11 22:00:34 CST 2024, time=2024-04-11, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2184149, encodeId=f961218414981, content=慢的死，这个杂志好慢，with editor半个月了，有人有经验么，想换个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Fri Jan 26 17:51:42 CST 2024, time=2024-01-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197730, encodeId=b939219e7305c, content=Mar 09, 2024投稿，现在还是在审稿中，无奈焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 10 13:16:34 CST 2024, time=2024-04-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿；1215送审；1月9号收到大修；2月2日返稿，2月14日接收，2月19日proof。大修要了所以WB原图，至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省)]
    2024-01-26 146d82c1m83暂无昵称 来自江苏省

    慢的死，这个杂志好慢，with editor半个月了，有人有经验么，想换个杂志了

    7

    展开7条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学;生信<br>经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：12.25投稿<br>2.27大修<br>3.17修回<br>4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199829, encodeId=394f2199829ce, content=大家一般with editor后多久转状态呀，好慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=ms9000001723608318, createdTime=Mon Apr 22 19:35:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198038, encodeId=5e352198038f0, content=偏重的研究方向：免疫药理<br>经验分享：这个期刊重复率有要求不能超过多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6655154625, createdName=木之禾66, createdTime=Thu Apr 11 22:00:34 CST 2024, time=2024-04-11, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2184149, encodeId=f961218414981, content=慢的死，这个杂志好慢，with editor半个月了，有人有经验么，想换个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Fri Jan 26 17:51:42 CST 2024, time=2024-01-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197730, encodeId=b939219e7305c, content=Mar 09, 2024投稿，现在还是在审稿中，无奈焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 10 13:16:34 CST 2024, time=2024-04-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿；1215送审；1月9号收到大修；2月2日返稿，2月14日接收，2月19日proof。大修要了所以WB原图，至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省)]
    2024-04-10 xgwan123 来自辽宁省

    Mar 09, 2024投稿，现在还是在审稿中，无奈焦急的等待

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2196947, encodeId=9cfd219694ee6, content=现在稿号到多少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Thu Apr 04 19:38:43 CST 2024, time=2024-04-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学;生信<br>经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200143, encodeId=5b47220014337, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：12.25投稿<br>2.27大修<br>3.17修回<br>4.18RRC到现在，是不是希望不大了，能写信催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b5c8431154, createdName=ms2000002142798745, createdTime=Wed Apr 24 15:50:12 CST 2024, time=2024-04-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199829, encodeId=394f2199829ce, content=大家一般with editor后多久转状态呀，好慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=ms9000001723608318, createdTime=Mon Apr 22 19:35:21 CST 2024, time=2024-04-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198038, encodeId=5e352198038f0, content=偏重的研究方向：免疫药理<br>经验分享：这个期刊重复率有要求不能超过多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6655154625, createdName=木之禾66, createdTime=Thu Apr 11 22:00:34 CST 2024, time=2024-04-11, status=1, ipAttribution=吉林), GetPortalCommentsPageByObjectIdResponse(id=2184149, encodeId=f961218414981, content=慢的死，这个杂志好慢，with editor半个月了，有人有经验么，想换个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4935171025, createdName=146d82c1m83暂无昵称, createdTime=Fri Jan 26 17:51:42 CST 2024, time=2024-01-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2197730, encodeId=b939219e7305c, content=Mar 09, 2024投稿，现在还是在审稿中，无奈焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 10 13:16:34 CST 2024, time=2024-04-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿；1215送审；1月9号收到大修；2月2日返稿，2月14日接收，2月19日proof。大修要了所以WB原图，至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省)]
    2024-02-21 yiyi11111111112 来自江苏省

    20231212日投稿；1215送审；1月9号收到大修；2月2日返稿，2月14日接收，2月19日proof。大修要了所以WB原图，至少三次的。还是挺严格的。

    5

    展开5条回复
共500条页码: 1/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分